Tuesday, 4 February 2018: Capillary blood collection devices can be referred to medical devices that are used to draw blood from human body to perform various diagnostic tests. These devices can be light-weight, easy to handle, and offer protection from contamination. Blood collection is expected to play important role in diagnostic procedures, which are performed at diagnostic centers and hospitals. Efficient diagnosis can help doctors know accurate medical condition of their patients. Hence, doctors can proceed with correct treatment and medication of patients in time.
New Lancet Based HIV Test to Deliver Accuracy
Major product variants of capillary blood collection devices are lancets, mic
ro-container tubes, micro hematocrit tubes, warming devices, and others. Lancets are expected to maintain their dominance during the forecast period attributed to increasing use in blood draw procedures. They are likely to offer small scalpel to puncture skin in order to collect blood sample. Rising cases of chronic diseases and infections can impel product demand in coming years. Reusable and disposable can be considered as two variants of lancets. Disposable lancets are expected to be used in hospital settings and clinics, where huge number of patients are tested for chronic diseases and infections. Reusable lancets are likely to be used in homecare settings for routine hemoglobin and glucose analysis in anemic and diabetic patients. Launch of advanced products by manufacturing companies to perform diagnostic tests can gain traction among consumers. For instance, Owen Mumford recently launched a diagnostic test of HIV that can provide accurate results within 15 minutes. This test called Simplitude Pro HIV, is expected to include built-in safety lancet (blood collection unit) and strip test to use blood as directly as possible. In addition, the device is expected to draw sufficient amount of blood to deliver accuracy.
Market Insights
The global capillary blood collection devices market is anticipated to reach USD 1.75 billion by 2025, according to a report by Grand View Research, Inc. Rising demand for POC diagnostics attributed to increasing cases of chronic cases across the globe. Increasing number of no communicable and infectious diseases is anticipated to give rise to chronic diseases. Antimicrobial resistance, poverty in developing countries, and rapid urbanization cab be considered as major factors that can lead to prevalence of various chronic diseases. Advent of advanced technologies in healthcare sector such as biosensors, bioanalytical platforms, novel assay formats, and other complementary research techniques can augment market growth. Availability of novel molecular technology can provide fast diagnosis at convenience and reduced costs. This, in turn, can influence growth of market in coming years. Increasing use of capillary blood collection devices in owing to its advantages like low cost, less invasive, and no requirement of professional for blood draw procedure can stimulate market growth.
Some of the leading companies operating in the market for capillary blood collection devices are Becton, Dickinson and Company, Terumo Medical Corporation, Cardinal Health, Owen Mumford Ltd., and Greiner Bio One International GmbH.
No comments:
Post a Comment